New Risk • Jul 09
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €86.7m (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks High level of debt (56% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Significant insider selling over the past 3 months (€195k sold). Market cap is less than US$100m (€86.7m market cap, or US$99.1m). Buy Or Sell Opportunity • Jul 08
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.0% to €3.35. The fair value is estimated to be €4.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last year. Earnings per share has grown by 18%. Reported Earnings • May 06
First quarter 2026 earnings released First quarter 2026 results: Revenue: €16.5m (down 4.3% from 1Q 2025). Net income: €1.12m (down 5.9% from 1Q 2025). Profit margin: 6.8% (down from 6.9% in 1Q 2025). The decrease in margin was driven by lower revenue. Announcement • May 05
Papoutsanis S.A. to Report Q1, 2026 Results on May 05, 2026 Papoutsanis S.A. announced that they will report Q1, 2026 results on May 05, 2026 Upcoming Dividend • Apr 14
Upcoming dividend of €0.05 per share Eligible shareholders must have bought the stock before 21 April 2026. Payment date: 27 April 2026. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of Greek dividend payers (5.3%). Lower than average of industry peers (2.7%). Announcement • Mar 16
Papoutsanis S.A., Annual General Meeting, Apr 17, 2026 Papoutsanis S.A., Annual General Meeting, Apr 17, 2026. Buy Or Sell Opportunity • Mar 03
Now 23% undervalued Over the last 90 days, the stock has risen 12% to €3.35. The fair value is estimated to be €4.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.5% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 22% in 2 years. Earnings are forecast to grow by 30% in the next 2 years. New Risk • Feb 04
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 5.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (5.7% average weekly change). Minor Risks High level of debt (54% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Recent Insider Transactions • Jan 16
CEO & Executive Member recently bought €190k worth of stock On the 14th of January, Menelaos Tassopoulos bought around 50k shares on-market at roughly €3.80 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Menelaos has been a buyer over the last 12 months, purchasing a net total of €320k worth in shares. Valuation Update With 7 Day Price Move • Dec 31
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €3.94, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Personal Products industry in Europe. Total returns to shareholders of 82% over the past three years. New Risk • Dec 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (58% net debt to equity). Share price has been volatile over the past 3 months (5.4% average weekly change). Significant insider selling over the past 3 months (€149k sold). Recent Insider Transactions • Nov 07
Executive Chairman recently sold €149k worth of stock On the 4th of November, Georgios Gatzaros sold around 50k shares on-market at roughly €3.00 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Georgios' only on-market trade for the last 12 months. New Risk • Oct 10
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. Cash payout ratio: 120% Dividend yield: 2.0% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks High level of debt (58% net debt to equity). Dividend is not well covered by cash flows (120% cash payout ratio). Market cap is less than US$100m (€81.6m market cap, or US$94.4m). Upcoming Dividend • Sep 30
Upcoming dividend of €0.04 per share Eligible shareholders must have bought the stock before 07 October 2025. Payment date: 13 October 2025. Payout ratio is a comfortable 13% but the company is paying out more than the cash it is generating. Trailing yield: 2.0%. Lower than top quartile of Greek dividend payers (5.1%). Lower than average of industry peers (2.4%). Price Target Changed • Sep 19
Price target increased by 10% to €3.20 Up from €2.90, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of €3.07. Stock is up 33% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.20 last year. Recent Insider Transactions • Sep 08
CEO & Executive Member recently bought €121k worth of stock On the 3rd of September, Menelaos Tassopoulos bought around 40k shares on-market at roughly €3.03 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Menelaos has been a buyer over the last 12 months, purchasing a net total of €164k worth in shares. Announcement • Aug 07
Papoutsanis S.A. to Report Nine Months, 2025 Results on Oct 30, 2025 Papoutsanis S.A. announced that they will report nine months, 2025 results on Oct 30, 2025 Reported Earnings • Aug 04
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: €23.0m (up 31% from 2Q 2024). Net income: €1.99m (up 22% from 2Q 2024). Profit margin: 8.7% (down from 9.3% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Personal Products industry in Europe. New Risk • Jul 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risks Share price has been volatile over the past 3 months (5.1% average weekly change). Market cap is less than US$100m (€81.3m market cap, or US$95.4m). Announcement • Jun 24
Papoutsanis S.A.(ATSE:PAP) dropped from ATHEX Composite Index Papoutsanis S.A.has been dropped from the the ATHEX Composite Index Reported Earnings • May 02
First quarter 2025 earnings released First quarter 2025 results: Revenue: €17.2m (up 21% from 1Q 2024). Net income: €1.19m (up 79% from 1Q 2024). Profit margin: 6.9% (up from 4.7% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Personal Products industry in Europe. Upcoming Dividend • Apr 21
Upcoming dividend of €0.03 per share Eligible shareholders must have bought the stock before 28 April 2025. Payment date: 05 May 2025. Trailing yield: 2.4%. Lower than top quartile of Greek dividend payers (6.4%). In line with average of industry peers (2.4%). Announcement • Mar 21
Papoutsanis S.A., Annual General Meeting, Apr 24, 2025 Papoutsanis S.A., Annual General Meeting, Apr 24, 2025. Upcoming Dividend • Nov 04
Upcoming dividend of €0.03 per share Eligible shareholders must have bought the stock before 11 November 2024. Payment date: 15 November 2024. Trailing yield: 3.1%. Lower than top quartile of Greek dividend payers (5.7%). Higher than average of industry peers (2.2%). Announcement • Oct 18
Papoutsanis S.A. to Report Q3, 2024 Results on Oct 22, 2024 Papoutsanis S.A. announced that they will report Q3, 2024 results on Oct 22, 2024 Announcement • Aug 02
Papoutsanis S.A. to Report First Half, 2024 Results on Aug 01, 2024 Papoutsanis S.A. announced that they will report first half, 2024 results on Aug 01, 2024 Announcement • May 01
Papoutsanis S.A. to Report Q1, 2024 Results on Apr 29, 2024 Papoutsanis S.A. announced that they will report Q1, 2024 results on Apr 29, 2024 Upcoming Dividend • Apr 12
Upcoming dividend of €0.04 per share Eligible shareholders must have bought the stock before 19 April 2024. Payment date: 25 April 2024. Trailing yield: 1.9%. Lower than top quartile of Greek dividend payers (5.2%). Lower than average of industry peers (2.2%). Announcement • Apr 02
Papoutsanis S.A., Annual General Meeting, Apr 17, 2024 Papoutsanis S.A., Annual General Meeting, Apr 17, 2024, at 11:00 E. Europe Standard Time. Location: Kalavriton 2 and Kaiafa, N. Kifissia of the Kifissia prefecture Kifissia Greece New Risk • Mar 30
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€66.1m market cap, or US$71.3m). Announcement • Mar 23
Papoutsanis S.A. to Report Q4, 2023 Results on Mar 26, 2024 Papoutsanis S.A. announced that they will report Q4, 2023 results on Mar 26, 2024 Price Target Changed • Mar 07
Price target decreased by 16% to €3.43 Down from €4.10, the current price target is an average from 2 analysts. New target price is 45% above last closing price of €2.37. Stock is down 1.3% over the past year. The company posted earnings per share of €0.18 last year. Announcement • Dec 19
Papoutsanis S.A.(ATSE:PAP) dropped from ATHEX Composite Index Papoutsanis S.A. has been dropped from ATHEX Composite Index . Upcoming Dividend • Nov 27
Upcoming dividend of €0.03 per share at 1.8% yield Eligible shareholders must have bought the stock before 04 December 2023. Payment date: 08 December 2023. Trailing yield: 1.8%. Lower than top quartile of Greek dividend payers (4.8%). In line with average of industry peers (1.8%). Announcement • Nov 09
Papoutsanis S.A. to Report Q3, 2023 Results on Nov 09, 2023 Papoutsanis S.A. announced that they will report Q3, 2023 results on Nov 09, 2023 Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €2.15, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 29x in the Personal Products industry in Europe. Total loss to shareholders of 2.0% over the past three years. Announcement • Aug 04
Papoutsanis S.A. to Report First Half, 2023 Results on Aug 04, 2023 Papoutsanis S.A. announced that they will report first half, 2023 results on Aug 04, 2023 Announcement • May 19
Papoutsanis S.A. to Report Q1, 2023 Results on May 17, 2023 Papoutsanis S.A. announced that they will report Q1, 2023 results on May 17, 2023 Upcoming Dividend • Nov 28
Upcoming dividend of €0.02 per share Eligible shareholders must have bought the stock before 05 December 2022. Payment date: 12 December 2022. Payout ratio is a comfortable 30% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of Greek dividend payers (5.4%). In line with average of industry peers (2.1%). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Antonios Barounas was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 09
Second quarter 2022 earnings released: EPS: €0.064 (vs €0.075 in 2Q 2021) Second quarter 2022 results: EPS: €0.064 (down from €0.075 in 2Q 2021). Revenue: €18.7m (up 34% from 2Q 2021). Net income: €1.72m (down 14% from 2Q 2021). Profit margin: 9.2% (down from 14% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Announcement • Aug 05
Papoutsanis S.A. to Report First Half, 2022 Results on Aug 04, 2022 Papoutsanis S.A. announced that they will report first half, 2022 results on Aug 04, 2022 Announcement • May 07
Papoutsanis S.A. to Report Q1, 2022 Results on May 09, 2022 Papoutsanis S.A. announced that they will report Q1, 2022 results on May 09, 2022 Buying Opportunity • Apr 27
Now 22% undervalued Over the last 90 days, the stock is up 6.6%. The fair value is estimated to be €3.72, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 51%. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Dimitrios Papoutsanis was the last independent director to join the board, commencing their role in 2010. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Apr 01
Papoutsanis S.A., Annual General Meeting, Apr 19, 2022 Papoutsanis S.A., Annual General Meeting, Apr 19, 2022, at 11:00 E. Europe Standard Time. Location: at 71st klm National Road Athens Lamia Greece Reported Earnings • Mar 14
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: €0.18 (up from €0.14 in FY 2020). Revenue: €54.8m (up 34% from FY 2020). Net income: €4.93m (up 29% from FY 2020). Profit margin: 9.0% (down from 9.4% in FY 2020). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 8.8%. Earnings per share (EPS) also missed analyst estimates by 14%. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 03
Third quarter 2021 earnings released: EPS €0.054 (vs €0.044 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: €14.0m (up 42% from 3Q 2020). Net income: €1.45m (up 23% from 3Q 2020). Profit margin: 10% (down from 12% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 05
Second quarter 2021 earnings released: EPS €0.075 (vs €0.068 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: €13.9m (up 8.1% from 2Q 2020). Net income: €2.01m (up 11% from 2Q 2020). Profit margin: 14% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 24
First quarter 2021 earnings released: EPS €0.02 (vs €0.018 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: €10.3m (up 28% from 1Q 2020). Net income: €538.6k (up 13% from 1Q 2020). Profit margin: 5.2% (down from 5.9% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 24
Full year 2020 earnings released: EPS €0.15 (vs €0.051 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €40.8m (up 33% from FY 2019). Net income: €3.82m (up 177% from FY 2019). Profit margin: 9.4% (up from 4.5% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth. Announcement • Mar 20
Papoutsanis S.A. to Report Fiscal Year 2020 Results on Mar 22, 2021 Papoutsanis S.A. announced that they will report fiscal year 2020 results on Mar 22, 2021 Announcement • Dec 04
Papoutsanis S.A., Annual General Meeting, Dec 23, 2020 Papoutsanis S.A., Annual General Meeting, Dec 23, 2020, at 11:00 E. Europe Standard Time. Reported Earnings • Oct 22
Third quarter earnings released Over the last 12 months the company has reported total profits of €3.80m, up 140% from the prior year. Total revenue was €39.1m over the last 12 months, up 38% from the prior year. Is New 90 Day High Low • Oct 21
New 90-day high: €2.55 The company is up 38% from its price of €1.85 on 23 July 2020. The Greek market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. Is New 90 Day High Low • Oct 05
New 90-day high: €2.27 The company is up 24% from its price of €1.83 on 07 July 2020. The Greek market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 2.0% over the same period. Announcement • Sep 12
Papoutsanis S.A. to Report First Half, 2020 Results on Jul 27, 2020 Papoutsanis S.A. announced that they will report first half, 2020 results on Jul 27, 2020